NCT05547386View on ClinicalTrials.gov

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

May 9, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Interventions
PROCEDURE

Computed Tomography

Undergo PET/CT scan

DRUG

Gallium Ga 68 Gozetotide

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT scan

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05547386 - 68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer | Biotech Hunter | Biotech Hunter